Presence of comorbidities and use of medications and nutritional supplements by women with weight regain after 24 months of gastric bypass

• Autor(a) principal: de Souza, Álina Célia Silva
• Data de Publicação: 2018
• Outros Autores: Gomes, Daniela Lopes, de Sá, Naiza Nayla Bandeira, de Carvalho, Kenia Mara Baiocchi
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Revista brasileira de obesidade, nutrição e emagrecimento
• Texto Completo: https://www.rbone.com.br/index.php/rbone/article/view/785
• topic: Obesity; Bariatric surgery; Associated diseases; Obesidad; Cirugia bariátrica; Enfermedades asociadas; Obesità; Chirurgia bariatrica; Malattie associate; Obesidade; Cirurgia bariátrica; Doenças associadas; Obesidade; Cirurgia bariátrica; Doenças associadas

Introduction: Individuals with severe obesity, without success in conventional clinical treatment, are indicated for surgical intervention, and the BYPASS gastric technique in Y by Roux (BGYR) is the most used. Objective: to describe the presence of comorbidities, use of medications and nutritional supplements by women with weight regan after 24 months of gastric BYPASS. Materials and methods: a descriptive cross-sectional study with 34 female patients submitted to BGYR, presenting recovering at least 5% of the lowest weight achieved after surgery. A questionnaire was used to collect sociodemographic data and the use of nutritional supplements and medications. Results: Participants had a mean age of 46.9 ± 11.2 years, Body Mass Index (BMI) of 35.7 ± 5.2 kg/m2 and a re-acquisition avarege of 12 ± 7.7 kg. The most frequent preoperative comorbidity was systemic arterial hypertension (SAH), followed by type 2 diabetes mellitus; In the postoperative period, it remained the SAH. Antihypertensives and hypoglycemic agents were the most common postoperative medications and half of the patients evaluated used all supplements. Discussion: Surgical success can be evaluated by BMI > 35 kg / m2 classified as surgical failure, and may predispose these patients to recurrence of comorbidities. Conclusion: The patients had an improvement in the frequency of comorbidities and consequently reduced the amount of medication used, however, the average comorbidities found, as well as the mean BMI still showed important frequency.